Novel risk model based on angiogenesis-related lncRNAs for prognosis prediction of hepatocellular carcinoma.

Novel risk model based on angiogenesis-related lncRNAs for prognosis prediction of hepatocellular carcinoma.
复制标题

基于血管生成相关lncrna的肝癌预后预测新风险模型

DOI:
10.1186/s12935-023-02975-x
复制
发表时间:
2023-08-07
影响因子:
5.8
通讯作者:
--
中科院分区:
医学2区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

Hepatocellular carcinoma (HCC) is a major cause of cancer-related death due to early metastasis or recurrence. Tumor angiogenesis plays an essential role in the tumorigenesis of HCC. Accumulated studies have validated the crucial role of lncRNAs in tumor angiogenesis. Here, we established an angiogenesis-related multi-lncRNAs risk model based on the machine learning for HCC prognosis prediction. Firstly, a total of 348 differential expression angiogenesis-related lncRNAs were identified by correlation analysis. Then, 20 of these lncRNAs were selected through univariate cox analysis and used for in-depth study of machine learning. After 1,000 random sampling cycles calculating by random forest algorithm, four lncRNAs were found to be highly associated with HCC prognosis, namely LUCAT1, AC010761.1, AC006504.7 and MIR210HG. Subsequently, the results from both the training and validation sets revealed that the four lncRNAs-based risk model was suitable for predicting HCC recurrence. Moreover, the infiltration of macrophages and CD8 T cells were shown to be closely associated with risk score and promotion of immune escape. The reliability of this model was validated by exploring the biological functions of lncRNA MIR210HG in HCC cells. The results showed that MIR210HG silence inhibited HCC growth and migration through upregulating PFKFB4 and SPAG4. Taken together, this angiogenesis-related risk model could serve as a reliable and promising tool to predict the prognosis of HCC. The online version contains supplementary material available at 10.1186/s12935-023-02975-x.
DOI: 10.3389/fonc.2021.624240
发表时间: 2021
影响因子: 4.7
作者:
Li H;Wang S;Yao Q;Liu Y;Yang J;Xu L;Yang G
通讯作者: Yang G
DOI: 10.1016/j.canlet.2021.11.006
发表时间: 2022-02-01
期刊: CANCER LETTERS
影响因子: 9.7
作者:
Li, Zhi-Yong;Xie, Ying;Lin, Xue-Jia
通讯作者: Lin, Xue-Jia
DOI: 10.1136/gutjnl-2013-305806
发表时间: 2014-11
期刊: Gut
影响因子: 24.5
作者:
Li J;Chen Z;Tian L;Zhou C;He MY;Gao Y;Wang S;Zhou F;Shi S;Feng X;Sun N;Liu Z;Skogerboe G;Dong J;Yao R;Zhao Y;Sun J;Zhang B;Yu Y;Shi X;Luo M;Shao K;Li N;Qiu B;Tan F;Chen R;He J
通讯作者: He J
DOI: 10.1053/j.gastro.2021.08.052
发表时间: 2021-12-11
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
Guo,Lin;Yi,Xianfu;Zhang,Ning
通讯作者: Zhang,Ning
DOI: 10.7150/thno.41365
发表时间: 2020-01-01
期刊: THERANOSTICS
影响因子: 12.4
作者:
Liu, Dong-Li;Lu, Li-Li;Wu, Wei-Zhong
通讯作者: Wu, Wei-Zhong